338 related articles for article (PubMed ID: 32877565)
1. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
Rowan SE; Kamis KF; Beum R; Bryan K; Gawenus L; Colon Sanchez D; Hurley H
J Infect Dis; 2020 Sep; 222(Suppl 5):S384-S391. PubMed ID: 32877565
[TBL] [Abstract][Full Text] [Related]
2. Rapid Versus Laboratory-Based Testing for HIV and Hepatitis C at a Drug Detoxification Treatment Center: A Randomized Trial.
Assoumou SA; Paniagua SM; Linas BP; Wang J; Samet JH; Hall J; White LF; Beckwith CG
J Infect Dis; 2020 Sep; 222(Suppl 5):S376-S383. PubMed ID: 32877557
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Among High-Risk Alabamians: Disease Burden and Screening Effectiveness.
Lee AB; Karumberia S; Gilmore A; Williams E; Bruner N; Overton ET; Saag MS; Franco RA
J Infect Dis; 2020 Sep; 222(Suppl 5):S365-S375. PubMed ID: 32877566
[TBL] [Abstract][Full Text] [Related]
4. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
5. On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial.
Frimpong JA; D'Aunno T; Perlman DC; Strauss SM; Mallow A; Hernandez D; Schackman BR; Feaster DJ; Metsch LR
Trials; 2016 Mar; 17(1):117. PubMed ID: 26936623
[TBL] [Abstract][Full Text] [Related]
6. A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs.
Frimpong JA; Parish CL; Feaster DJ; Gooden LK; Nelson MC; Matheson T; Siegel K; Haynes L; Linas BP; Assoumou SA; Tross S; Kyle T; Liguori TK; Toussaint O; Annane D; Metsch LR
Trials; 2023 Sep; 24(1):609. PubMed ID: 37749635
[TBL] [Abstract][Full Text] [Related]
7. Provision of and Barriers to Integrating Reproductive and Sexual Health Services for Reproductive-age Women in Opioid Treatment Programs.
Klaman SL; Lorvick J; Jones HE
J Addict Med; 2019; 13(6):422-429. PubMed ID: 31689259
[TBL] [Abstract][Full Text] [Related]
8. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.
Carey KJ; Huang W; Linas BP; Tsui JI
J Subst Abuse Treat; 2016 Jul; 66():54-9. PubMed ID: 26988423
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of hepatitis C virus infection among incarcerated persons: Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program in prisons.
Irvin R; Landry G; Jones MR; James A; Schexnayder J; Rodriguez S; Wendell D; Barthe K; Britton E; LeSar K; Manogue S; Sugarman OK; Brown C; Burgess S; Mehta SH; Thomas DL; Robinson W;
J Viral Hepat; 2024 Jul; 31(7):432-435. PubMed ID: 38758571
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.
Cipriano LE; Zaric GS; Holodniy M; Bendavid E; Owens DK; Brandeau ML
PLoS One; 2012; 7(9):e45176. PubMed ID: 23028828
[TBL] [Abstract][Full Text] [Related]
13. Routine screening for hepatitis C viral infection in patients undergoing elective cranial neurosurgery.
Nussbaum ES; Kallmes K; Lowary J; Nussbaum LA
J Neurosurg; 2018 Sep; 131(3):941-948. PubMed ID: 30215562
[TBL] [Abstract][Full Text] [Related]
14. Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.
Coyle C; Viner K; Hughes E; Kwakwa H; Zibbell JE; Vellozzi C; Holtzman D;
MMWR Morb Mortal Wkly Rep; 2015 May; 64(17):459-63. PubMed ID: 25950252
[TBL] [Abstract][Full Text] [Related]
15. HIV and HCV screening among trauma patients.
Simoncini GM; Oyola-Jimenez J; Singleton D; Volgraf J; Ramsey FV; Goldberg A
Int J STD AIDS; 2019 Jun; 30(7):663-670. PubMed ID: 30961465
[TBL] [Abstract][Full Text] [Related]
16. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
17. Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study.
Sanvisens A; Rivas I; Faure E; Espinach N; Hernandez-Rubio A; Majó X; Colom J; Muga R
World J Gastroenterol; 2020 Oct; 26(38):5874-5883. PubMed ID: 33132641
[TBL] [Abstract][Full Text] [Related]
18. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
19. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India.
Saravanan S; Velu V; Kumarasamy N; Nandakumar S; Murugavel KG; Balakrishnan P; Suniti S; Thyagarajan SP
World J Gastroenterol; 2007 Oct; 13(37):5015-20. PubMed ID: 17854146
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
Fang CT; Field SP; Busch MP; Heyns Adu P
Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
